

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 4.65504854 |
| 2 | flavonoid metabolic process (GO:0009812) | 4.33566961 |
| 3 | exogenous drug catabolic process (GO:0042738) | 4.31158304 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 4.20596325 |
| 5 | cellular glucuronidation (GO:0052695) | 3.68602301 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 3.66229672 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 3.66229672 |
| 8 | tryptophan catabolic process (GO:0006569) | 3.66229672 |
| 9 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65349215 |
| 10 | drug metabolic process (GO:0017144) | 3.48907316 |
| 11 | regulation of protein activation cascade (GO:2000257) | 3.46829426 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 3.45212971 |
| 13 | ethanol oxidation (GO:0006069) | 3.44233891 |
| 14 | oxidative demethylation (GO:0070989) | 3.43151295 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 3.40057971 |
| 16 | glucuronate metabolic process (GO:0019585) | 3.39978832 |
| 17 | uronic acid metabolic process (GO:0006063) | 3.39978832 |
| 18 | negative regulation of protein activation cascade (GO:2000258) | 3.38885209 |
| 19 | glyoxylate metabolic process (GO:0046487) | 3.35063399 |
| 20 | regulation of complement activation (GO:0030449) | 3.31842875 |
| 21 | negative regulation of complement activation (GO:0045916) | 3.25869009 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 3.25049770 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.21203753 |
| 24 | reverse cholesterol transport (GO:0043691) | 3.18423720 |
| 25 | bile acid metabolic process (GO:0008206) | 3.13732461 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 3.10728287 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.10614809 |
| 28 | L-phenylalanine catabolic process (GO:0006559) | 3.10614809 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 3.05115525 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 3.01411881 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 3.00421002 |
| 32 | bile acid and bile salt transport (GO:0015721) | 2.99681442 |
| 33 | bile acid biosynthetic process (GO:0006699) | 2.97917661 |
| 34 | regulation of fibrinolysis (GO:0051917) | 2.97670298 |
| 35 | macromolecular complex remodeling (GO:0034367) | 2.97608822 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 2.97608822 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 2.97608822 |
| 38 | intestinal cholesterol absorption (GO:0030299) | 2.96538494 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 2.95667404 |
| 40 | skeletal muscle adaptation (GO:0043501) | 2.95176598 |
| 41 | regulation of hippo signaling (GO:0035330) | 2.94117344 |
| 42 | tryptophan metabolic process (GO:0006568) | 2.91194785 |
| 43 | ethanol metabolic process (GO:0006067) | 2.90886433 |
| 44 | phospholipid homeostasis (GO:0055091) | 2.88553182 |
| 45 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.85815191 |
| 46 | omega-hydroxylase P450 pathway (GO:0097267) | 2.85162144 |
| 47 | L-phenylalanine metabolic process (GO:0006558) | 2.84361040 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.84361040 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 2.83201493 |
| 50 | negative regulation of sodium ion transport (GO:0010766) | 2.82455465 |
| 51 | phenylpropanoid metabolic process (GO:0009698) | 2.82166747 |
| 52 | intestinal absorption (GO:0050892) | 2.81649848 |
| 53 | alkaloid metabolic process (GO:0009820) | 2.81021519 |
| 54 | regulation of bile acid biosynthetic process (GO:0070857) | 2.80037610 |
| 55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.76985844 |
| 56 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.72379924 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.69907586 |
| 58 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.69540232 |
| 59 | negative regulation of protein localization to cell surface (GO:2000009) | 2.69238905 |
| 60 | phospholipid efflux (GO:0033700) | 2.68962758 |
| 61 | cellular response to sterol (GO:0036315) | 2.67402548 |
| 62 | drug transmembrane transport (GO:0006855) | 2.66103067 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 2.65296139 |
| 64 | dicarboxylic acid catabolic process (GO:0043649) | 2.65093415 |
| 65 | negative regulation of lipase activity (GO:0060192) | 2.64814141 |
| 66 | negative regulation of sterol transport (GO:0032372) | 2.64385028 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 2.64385028 |
| 68 | triglyceride homeostasis (GO:0070328) | 2.63903075 |
| 69 | acylglycerol homeostasis (GO:0055090) | 2.63903075 |
| 70 | cholesterol efflux (GO:0033344) | 2.62252904 |
| 71 | ketone body metabolic process (GO:1902224) | 2.60938478 |
| 72 | C4-dicarboxylate transport (GO:0015740) | 2.60240818 |
| 73 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.59467915 |
| 74 | macroautophagy (GO:0016236) | 2.57914455 |
| 75 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.57536006 |
| 76 | carnitine shuttle (GO:0006853) | 2.56939102 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 2.56352618 |
| 78 | striated muscle atrophy (GO:0014891) | 2.56004719 |
| 79 | arginine metabolic process (GO:0006525) | 2.55454821 |
| 80 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.54265287 |
| 81 | auditory receptor cell stereocilium organization (GO:0060088) | 2.53654305 |
| 82 | urea metabolic process (GO:0019627) | 2.53352637 |
| 83 | creatine metabolic process (GO:0006600) | 2.53321844 |
| 84 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.52099789 |
| 85 | lipoprotein metabolic process (GO:0042157) | 2.52064128 |
| 86 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49715985 |
| 87 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.48348912 |
| 88 | heme transport (GO:0015886) | 2.46841792 |
| 89 | amino-acid betaine transport (GO:0015838) | 2.45333227 |
| 90 | carnitine transport (GO:0015879) | 2.45333227 |
| 91 | protein carboxylation (GO:0018214) | 2.45237037 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.45237037 |
| 93 | neuronal action potential propagation (GO:0019227) | 2.43749688 |
| 94 | regulation of cholesterol esterification (GO:0010872) | 2.42758661 |
| 95 | regulation of sarcomere organization (GO:0060297) | 2.41768931 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 2.40056892 |
| 97 | quaternary ammonium group transport (GO:0015697) | 2.39796446 |
| 98 | negative regulation of humoral immune response (GO:0002921) | 2.39506317 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 2.39281852 |
| 100 | positive regulation of fatty acid oxidation (GO:0046321) | 2.39210242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.83000148 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.47681985 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.28052872 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.26476808 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.23370412 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.19825837 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17345853 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.15550721 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.08916041 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.05788664 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97005845 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94361959 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82954766 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.81544287 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77571756 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75046032 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73360899 |
| 18 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69496394 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.69105593 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.68238458 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66771289 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.65362825 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64286835 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.63773089 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60124106 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59742966 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.58897971 |
| 28 | STAT3_23295773_ChIP-Seq_U87_Human | 1.55865096 |
| 29 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.52032669 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50565181 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46978151 |
| 32 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45564636 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45262400 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44769498 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42844127 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41375483 |
| 37 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.41215671 |
| 38 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.39005091 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38433018 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37695653 |
| 41 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36570304 |
| 42 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35987095 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33587584 |
| 44 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.33418247 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33255595 |
| 46 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32726105 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30803142 |
| 48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28878067 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.27844927 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24882354 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23836605 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23165063 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23135413 |
| 54 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19415851 |
| 55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19006214 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18401167 |
| 57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17366696 |
| 58 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.17049254 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16793734 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16101137 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16101137 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14884203 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14507867 |
| 64 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.14376698 |
| 65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14231193 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13343492 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13149703 |
| 68 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12487564 |
| 69 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11749540 |
| 70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11706474 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11586662 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09517984 |
| 73 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09504245 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09140042 |
| 75 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08910627 |
| 76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08850587 |
| 77 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06652130 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06526411 |
| 79 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06512615 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06223038 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05036064 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04532085 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04400060 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04112744 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04112744 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03588918 |
| 87 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.03198087 |
| 88 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02969860 |
| 89 | * AR_19668381_ChIP-Seq_PC3_Human | 1.02403819 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00813011 |
| 91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00246773 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99797414 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99797414 |
| 94 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97979613 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97891645 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97643869 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96404727 |
| 98 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.95531796 |
| 99 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.95397899 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94693102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.53167916 |
| 2 | MP0005360_urolithiasis | 4.30083744 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.27992996 |
| 4 | MP0003195_calcinosis | 3.70759022 |
| 5 | MP0003646_muscle_fatigue | 3.53355031 |
| 6 | MP0005365_abnormal_bile_salt | 3.50898760 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 3.02983690 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.02952289 |
| 9 | MP0003868_abnormal_feces_composition | 2.57208125 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56335993 |
| 11 | MP0003252_abnormal_bile_duct | 2.45155220 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.44204902 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.33711598 |
| 14 | MP0004043_abnormal_pH_regulation | 2.28637116 |
| 15 | MP0004270_analgesia | 2.14907907 |
| 16 | MP0003879_abnormal_hair_cell | 2.03295088 |
| 17 | MP0005670_abnormal_white_adipose | 2.02651105 |
| 18 | MP0001501_abnormal_sleep_pattern | 1.89992274 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.89073801 |
| 20 | MP0004130_abnormal_muscle_cell | 1.87750482 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 1.87742911 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.82738686 |
| 23 | MP0003045_fibrosis | 1.80635731 |
| 24 | MP0000569_abnormal_digit_pigmentation | 1.69308679 |
| 25 | MP0004036_abnormal_muscle_relaxation | 1.64122552 |
| 26 | MP0004147_increased_porphyrin_level | 1.63632766 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.63615075 |
| 28 | MP0000749_muscle_degeneration | 1.59758683 |
| 29 | MP0005332_abnormal_amino_acid | 1.49672553 |
| 30 | MP0000751_myopathy | 1.46178952 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.38398626 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.37599320 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.32084688 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.30074792 |
| 35 | MP0002168_other_aberrant_phenotype | 1.28321294 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.25156440 |
| 37 | MP0000383_abnormal_hair_follicle | 1.20773542 |
| 38 | MP0001486_abnormal_startle_reflex | 1.15598700 |
| 39 | MP0002971_abnormal_brown_adipose | 1.12651451 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.11318525 |
| 41 | MP0002106_abnormal_muscle_physiology | 1.10749679 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.09135275 |
| 43 | MP0009046_muscle_twitch | 1.07774884 |
| 44 | MP0001664_abnormal_digestion | 1.07728732 |
| 45 | MP0008872_abnormal_physiological_respon | 1.06150469 |
| 46 | MP0001485_abnormal_pinna_reflex | 1.06047796 |
| 47 | MP0009745_abnormal_behavioral_response | 1.05897681 |
| 48 | MP0002064_seizures | 1.05354523 |
| 49 | MP0004233_abnormal_muscle_weight | 1.03992023 |
| 50 | MP0000427_abnormal_hair_cycle | 1.00386576 |
| 51 | MP0002332_abnormal_exercise_endurance | 0.99630716 |
| 52 | MP0010678_abnormal_skin_adnexa | 0.98902443 |
| 53 | MP0005409_darkened_coat_color | 0.97536051 |
| 54 | MP0000538_abnormal_urinary_bladder | 0.96873686 |
| 55 | MP0000579_abnormal_nail_morphology | 0.96513481 |
| 56 | MP0001968_abnormal_touch/_nociception | 0.94823479 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 0.94755823 |
| 58 | MP0001765_abnormal_ion_homeostasis | 0.94567362 |
| 59 | MP0000747_muscle_weakness | 0.93513974 |
| 60 | MP0005266_abnormal_metabolism | 0.91894866 |
| 61 | MP0005369_muscle_phenotype | 0.91395541 |
| 62 | MP0005083_abnormal_biliary_tract | 0.88593344 |
| 63 | MP0002272_abnormal_nervous_system | 0.86682882 |
| 64 | MP0009643_abnormal_urine_homeostasis | 0.85106682 |
| 65 | MP0002269_muscular_atrophy | 0.83461510 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.83034746 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 0.82734539 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.82170642 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 0.81920743 |
| 70 | MP0004087_abnormal_muscle_fiber | 0.81799438 |
| 71 | MP0005451_abnormal_body_composition | 0.81628302 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 0.81460256 |
| 73 | MP0002736_abnormal_nociception_after | 0.81024642 |
| 74 | MP0004215_abnormal_myocardial_fiber | 0.80687318 |
| 75 | MP0004084_abnormal_cardiac_muscle | 0.80167536 |
| 76 | MP0003635_abnormal_synaptic_transmissio | 0.79254202 |
| 77 | MP0001756_abnormal_urination | 0.77876688 |
| 78 | MP0005386_behavior/neurological_phenoty | 0.77760531 |
| 79 | MP0004924_abnormal_behavior | 0.77760531 |
| 80 | MP0005395_other_phenotype | 0.77207755 |
| 81 | MP0002909_abnormal_adrenal_gland | 0.76936294 |
| 82 | MP0010368_abnormal_lymphatic_system | 0.73076389 |
| 83 | MP0000609_abnormal_liver_physiology | 0.72851986 |
| 84 | MP0005330_cardiomyopathy | 0.72824691 |
| 85 | MP0001984_abnormal_olfaction | 0.72508150 |
| 86 | MP0004484_altered_response_of | 0.71852878 |
| 87 | MP0001764_abnormal_homeostasis | 0.71809095 |
| 88 | MP0003633_abnormal_nervous_system | 0.71695109 |
| 89 | MP0009840_abnormal_foam_cell | 0.71264140 |
| 90 | MP0003632_abnormal_nervous_system | 0.70880900 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.70105938 |
| 92 | MP0009697_abnormal_copulation | 0.69932346 |
| 93 | MP0000566_synostosis | 0.69857835 |
| 94 | MP0004885_abnormal_endolymph | 0.69203048 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.68647260 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.68400515 |
| 97 | MP0006138_congestive_heart_failure | 0.68124321 |
| 98 | MP0001661_extended_life_span | 0.67097888 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.66889678 |
| 100 | MP0002229_neurodegeneration | 0.66195860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 4.65057106 |
| 2 | Nemaline bodies (HP:0003798) | 4.45297917 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.43155772 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.32045037 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 4.17970274 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.15078641 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.05810931 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.01334767 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92292740 |
| 10 | Genetic anticipation (HP:0003743) | 3.91608605 |
| 11 | Hydroxyprolinuria (HP:0003080) | 3.55528594 |
| 12 | Abnormality of proline metabolism (HP:0010907) | 3.55528594 |
| 13 | Hyperventilation (HP:0002883) | 3.51566882 |
| 14 | Hyperkalemia (HP:0002153) | 3.20843997 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.18418416 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 3.15448116 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.07089756 |
| 18 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.94667583 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 2.93783872 |
| 20 | Hyperglycinuria (HP:0003108) | 2.91347502 |
| 21 | Complement deficiency (HP:0004431) | 2.91319381 |
| 22 | Dysmetric saccades (HP:0000641) | 2.83320767 |
| 23 | Hypolipoproteinemia (HP:0010981) | 2.73544355 |
| 24 | Fair hair (HP:0002286) | 2.71007359 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 2.66237601 |
| 26 | Distal arthrogryposis (HP:0005684) | 2.64219872 |
| 27 | Type 1 muscle fiber predominance (HP:0003803) | 2.56664472 |
| 28 | Decreased circulating renin level (HP:0003351) | 2.53697827 |
| 29 | Clumsiness (HP:0002312) | 2.47994498 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47372225 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 2.47372225 |
| 32 | Ileus (HP:0002595) | 2.45292336 |
| 33 | Facial diplegia (HP:0001349) | 2.45233422 |
| 34 | Fat malabsorption (HP:0002630) | 2.45048648 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.43718505 |
| 36 | Intrahepatic cholestasis (HP:0001406) | 2.43328297 |
| 37 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.42920661 |
| 38 | Abnormality of potassium homeostasis (HP:0011042) | 2.42258296 |
| 39 | Epidermoid cyst (HP:0200040) | 2.41884968 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 2.40270076 |
| 41 | Febrile seizures (HP:0002373) | 2.37931360 |
| 42 | Xanthomatosis (HP:0000991) | 2.36823803 |
| 43 | Proximal tubulopathy (HP:0000114) | 2.34803230 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 2.33175097 |
| 45 | Areflexia of lower limbs (HP:0002522) | 2.31559703 |
| 46 | Abnormality of the ischium (HP:0003174) | 2.27979377 |
| 47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27822849 |
| 48 | Joint hemorrhage (HP:0005261) | 2.23731233 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.17824913 |
| 50 | Myopathic facies (HP:0002058) | 2.17442873 |
| 51 | Bundle branch block (HP:0011710) | 2.15703698 |
| 52 | Focal seizures (HP:0007359) | 2.15600180 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.14936580 |
| 54 | Myoglobinuria (HP:0002913) | 2.12762940 |
| 55 | Hypokalemia (HP:0002900) | 2.12165581 |
| 56 | Congenital sensorineural hearing impairment (HP:0008527) | 2.12107651 |
| 57 | Pigmentary retinal degeneration (HP:0001146) | 2.10752536 |
| 58 | Hyperlipoproteinemia (HP:0010980) | 2.10680928 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.08105977 |
| 60 | Abnormality of the calf musculature (HP:0001430) | 2.07726477 |
| 61 | Bronchomalacia (HP:0002780) | 2.06476177 |
| 62 | Central scotoma (HP:0000603) | 2.06179544 |
| 63 | Potter facies (HP:0002009) | 2.05542301 |
| 64 | Facial shape deformation (HP:0011334) | 2.05542301 |
| 65 | Glomerulonephritis (HP:0000099) | 2.04851887 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.03858348 |
| 67 | Abnormality of the renal cortex (HP:0011035) | 2.02078064 |
| 68 | Enlarged kidneys (HP:0000105) | 2.00918293 |
| 69 | Vascular calcification (HP:0004934) | 2.00069078 |
| 70 | Absence seizures (HP:0002121) | 1.99966546 |
| 71 | Amelogenesis imperfecta (HP:0000705) | 1.97061744 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92899301 |
| 73 | Abnormality of renin-angiotensin system (HP:0000847) | 1.92391560 |
| 74 | Difficulty running (HP:0009046) | 1.92293736 |
| 75 | Dialeptic seizures (HP:0011146) | 1.92077613 |
| 76 | Round ear (HP:0100830) | 1.91916170 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 1.90551922 |
| 78 | Focal motor seizures (HP:0011153) | 1.90424457 |
| 79 | Acanthocytosis (HP:0001927) | 1.89039457 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 1.87212380 |
| 81 | Blue irides (HP:0000635) | 1.84884594 |
| 82 | Abnormality of binocular vision (HP:0011514) | 1.83712214 |
| 83 | Diplopia (HP:0000651) | 1.83712214 |
| 84 | Hypoalphalipoproteinemia (HP:0003233) | 1.82855935 |
| 85 | Hyperammonemia (HP:0001987) | 1.82066657 |
| 86 | Postural instability (HP:0002172) | 1.79511950 |
| 87 | Abnormality of complement system (HP:0005339) | 1.79366980 |
| 88 | Metabolic alkalosis (HP:0200114) | 1.77972635 |
| 89 | Hemorrhage of the eye (HP:0011885) | 1.77922848 |
| 90 | Abnormality of the nasal septum (HP:0000419) | 1.76879249 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 1.76757835 |
| 92 | Difficulty walking (HP:0002355) | 1.76324718 |
| 93 | Flat acetabular roof (HP:0003180) | 1.75384826 |
| 94 | Broad-based gait (HP:0002136) | 1.75237327 |
| 95 | Ketosis (HP:0001946) | 1.74293801 |
| 96 | Abnormality of the pubic bones (HP:0003172) | 1.74101058 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 1.72886887 |
| 98 | Abnormality of the intrinsic pathway (HP:0010989) | 1.72822366 |
| 99 | Absent phalangeal crease (HP:0006109) | 1.71781635 |
| 100 | Syncope (HP:0001279) | 1.71594379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 7.69952369 |
| 2 | OBSCN | 4.48058598 |
| 3 | ACVR1B | 3.24248209 |
| 4 | PHKG2 | 2.78836569 |
| 5 | PHKG1 | 2.78836569 |
| 6 | LATS1 | 2.14840657 |
| 7 | PIK3CG | 1.97038768 |
| 8 | PIK3CA | 1.91700472 |
| 9 | BMPR1B | 1.80499272 |
| 10 | NTRK3 | 1.77483563 |
| 11 | CASK | 1.74381836 |
| 12 | RIPK1 | 1.66483916 |
| 13 | MAPKAPK3 | 1.66429222 |
| 14 | STK39 | 1.60983037 |
| 15 | PRKAA2 | 1.51878790 |
| 16 | CDK12 | 1.51366010 |
| 17 | AKT3 | 1.45388486 |
| 18 | PINK1 | 1.43858440 |
| 19 | MST1R | 1.43352027 |
| 20 | FER | 1.41622453 |
| 21 | OXSR1 | 1.39352623 |
| 22 | MAP3K7 | 1.37436539 |
| 23 | EPHA2 | 1.36408353 |
| 24 | MARK1 | 1.35166304 |
| 25 | EPHA4 | 1.34443021 |
| 26 | TTN | 1.31571931 |
| 27 | STK38L | 1.28150113 |
| 28 | ADRBK2 | 1.23521636 |
| 29 | INSRR | 1.20927560 |
| 30 | FGFR3 | 1.12097282 |
| 31 | MAPK13 | 1.10429354 |
| 32 | MUSK | 1.09354540 |
| 33 | DAPK2 | 1.01041379 |
| 34 | ERBB2 | 0.99452577 |
| 35 | SGK2 | 0.97665947 |
| 36 | PRKAA1 | 0.96187996 |
| 37 | STK38 | 0.91789440 |
| 38 | MAPK11 | 0.89983264 |
| 39 | LMTK2 | 0.89215969 |
| 40 | FGFR4 | 0.86139065 |
| 41 | MET | 0.84843282 |
| 42 | MAP2K6 | 0.80682928 |
| 43 | GRK1 | 0.78399590 |
| 44 | ICK | 0.75803618 |
| 45 | SGK223 | 0.74956435 |
| 46 | SGK494 | 0.74956435 |
| 47 | MAP2K1 | 0.74816443 |
| 48 | TNK2 | 0.74049655 |
| 49 | NTRK2 | 0.72182828 |
| 50 | WNK4 | 0.71300389 |
| 51 | MAP3K2 | 0.71097391 |
| 52 | TRPM7 | 0.70779440 |
| 53 | EPHA3 | 0.70717917 |
| 54 | SGK1 | 0.69802225 |
| 55 | CAMK2A | 0.68966513 |
| 56 | MELK | 0.68669718 |
| 57 | CAMK2G | 0.67839478 |
| 58 | CAMK1D | 0.67363397 |
| 59 | FGFR2 | 0.67231113 |
| 60 | NLK | 0.67104719 |
| 61 | CAMK1G | 0.66419261 |
| 62 | CAMK2B | 0.65453809 |
| 63 | PKN2 | 0.64776640 |
| 64 | MAP4K2 | 0.64657916 |
| 65 | SGK3 | 0.63227521 |
| 66 | MAP2K4 | 0.62323126 |
| 67 | TRIB3 | 0.62145191 |
| 68 | CAMK4 | 0.61846028 |
| 69 | TAOK3 | 0.60781487 |
| 70 | ADRBK1 | 0.60678041 |
| 71 | CAMK2D | 0.55437982 |
| 72 | PRKCE | 0.55407489 |
| 73 | TNIK | 0.53769604 |
| 74 | PRKG1 | 0.52765241 |
| 75 | EEF2K | 0.52204893 |
| 76 | MAP2K2 | 0.52175113 |
| 77 | NEK6 | 0.51366956 |
| 78 | MAPK12 | 0.50635782 |
| 79 | RET | 0.47518843 |
| 80 | MAP3K4 | 0.46674362 |
| 81 | PRKD3 | 0.46279899 |
| 82 | PRKG2 | 0.46223195 |
| 83 | CAMK1 | 0.45868254 |
| 84 | PDK1 | 0.45497897 |
| 85 | RPS6KA3 | 0.45369300 |
| 86 | PRKCG | 0.45015116 |
| 87 | PDPK1 | 0.44517954 |
| 88 | MAPKAPK5 | 0.42974019 |
| 89 | CDC42BPA | 0.42428458 |
| 90 | PRKACG | 0.42244338 |
| 91 | ROCK1 | 0.41934008 |
| 92 | WNK3 | 0.41029029 |
| 93 | PRKACA | 0.41008825 |
| 94 | MTOR | 0.39601404 |
| 95 | RPS6KB1 | 0.37704270 |
| 96 | PTK2B | 0.37512038 |
| 97 | PKN1 | 0.37114840 |
| 98 | CSNK1D | 0.36658981 |
| 99 | WNK1 | 0.36086459 |
| 100 | PRKCZ | 0.36048430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90486502 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.71307566 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.58349086 |
| 4 | Histidine metabolism_Homo sapiens_hsa00340 | 2.56958897 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.31678882 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.30700180 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30069883 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.25595407 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16265389 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.16214704 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11587391 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.08348455 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.04691629 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.04427802 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98061244 |
| 16 | ABC transporters_Homo sapiens_hsa02010 | 1.94003215 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.93923912 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91866600 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.88679277 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78747140 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.72596057 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65352268 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60142977 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56299845 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53271243 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48717823 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43364939 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43294711 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42742927 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.40347523 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39791235 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30713372 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25507849 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25181253 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23137219 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19511792 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13529782 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12481693 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.10963152 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.10568870 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09854271 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 1.06170879 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05428960 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97554287 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96520922 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89866427 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89860257 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85144990 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 0.81227052 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78632592 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76196710 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75883574 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75684197 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.75340169 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74785330 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72377671 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.71959741 |
| 58 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70929276 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70899421 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69386948 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67601760 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66443634 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.66078189 |
| 64 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65805252 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65536120 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.64432406 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64092868 |
| 68 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63299583 |
| 69 | Salivary secretion_Homo sapiens_hsa04970 | 0.62756652 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.62323097 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61606594 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57836167 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57549579 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55817035 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55514575 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55393810 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.55134900 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52152290 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51945789 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51149724 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50799795 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50276742 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49186750 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46804734 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44726120 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42358864 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.42190500 |
| 88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41750146 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40749964 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39885883 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38890466 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36088211 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35840505 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.34883194 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34840447 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34779033 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34662336 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34085823 |
| 99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32378225 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.32300737 |

